$1.63
-0.15-8.43%
Last update: Nov 10, 2:57 PM
Tenax Therapeutics Inc
TENXNASDAQ
Tenax Therapeutics fell 74.6% from $7.01 to $1.78, behind the S&P 500's +10.5%. Its worst day was Aug 10 (−89.8%), and its low came Oct 16 at $1.36.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.40 beat the $-1.21 estimate on $0.00 revenue.
−4.3% · S&P 500 −1.7%
Tenax Therapeutics shares rose 21.4%, while the S&P 500 fell 0.5%.
Story events cover the past 12 months · Times ET
+21.4% · S&P 500 −0.5%
EPS of $-0.38 beat the $-0.75 estimate on $0.00 revenue.
+31.7%, the year's best day · S&P 500 −0.2%
EPS of $-0.35 beat the $-0.40 estimate on $0.00 revenue.
+1.8% · S&P 500 −0.2%
Tenax Therapeutics closed at its highest level of the year, 161.3% above where the year started.
+3.3% · S&P 500 +0.8%
EPS of $-0.35 beat the $-0.37 estimate on $0.00 revenue.
−9.3% · S&P 500 +0.7%
TNX-103 did not meet statistical significance on the primary endpoint of improvement in 6-minute walk distance versus placeboIn prespecified exploratory analyses in the overall trial population, treatment with TNX-103
−89.8%, the year's worst day, on 66M shares, the year's heaviest volume · S&P 500 0.0%
Tenax Therapeutics shares rose 25.4%, while the S&P 500 rose 0.3%.
+25.4% · S&P 500 +0.3%
Tenax Therapeutics closed at its lowest level of the year, 80.6% below where the year started.
−9.9% · S&P 500 −1.1%
EPS of $-0.31 beat the $-0.36 estimate on $0.00 revenue.
−9.9% · S&P 500 −4.4%
Where it ended: a close of $1.78 on Nov 9, 2026. Up next: Q4 2026 earnings on Mar 9, 2027 (EPS est. $-0.35).
Nothing in the past 12 months.
All TENX dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TENX and SPY from Benzinga historical bars. Not investment advice.
